WO2011152772A1 - Medicament delivery device - Google Patents
Medicament delivery device Download PDFInfo
- Publication number
- WO2011152772A1 WO2011152772A1 PCT/SE2011/050582 SE2011050582W WO2011152772A1 WO 2011152772 A1 WO2011152772 A1 WO 2011152772A1 SE 2011050582 W SE2011050582 W SE 2011050582W WO 2011152772 A1 WO2011152772 A1 WO 2011152772A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- delivery device
- push means
- driver
- release member
- guide member
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31566—Means improving security or handling thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
- A61M5/31583—Constructional features or modes of drive mechanisms for piston rods based on rotational translation, i.e. movement of piston rod is caused by relative rotation between the user activated actuator and the piston rod
- A61M5/31585—Constructional features or modes of drive mechanisms for piston rods based on rotational translation, i.e. movement of piston rod is caused by relative rotation between the user activated actuator and the piston rod performed by axially moving actuator, e.g. an injection button
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M2005/2026—Semi-automatic, e.g. user activated piston is assisted by additional source of energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31566—Means improving security or handling thereof
- A61M5/3157—Means providing feedback signals when administration is completed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31566—Means improving security or handling thereof
- A61M5/31571—Means preventing accidental administration
Definitions
- the present invention relates to a medicament delivery device for delivering medicament and in particular to a medicament delivery device where safety and handling aspects have been improved by the interaction of a lockable injection button and a release button.
- a medicament delivery device is a device that is simple to use without the need of performing many steps when an individual has to administer a dose of medicament by himself/herself. This requires a solution able of keeping a
- medicament delivery device as pre-assembled and ready as possible, in order to deliver the medicament in a measured dosage, without many manual operations or actions.
- some known prior art devices only need to be actuated against the delivery area, without the need of manual actuation, by pressing a button or the like, which causes the medicament delivery device to perform the delivery.
- a medicament delivery device which is very easy to use and which can reliably deliver a set dose of a medicament in a safe way.
- US 5,925,021 discloses a pen injector device comprising a locking means for locking the actuator knob in a depressed position, a start button for releasing the actuator button and a dosage knob for setting a prescribed dose.
- US 5,925,021 also comprises electronics, such as sensors and display devices for controlling the injection, for measuring and storing ejected doses and for displaying information to the user.
- a disadvantage of this prior art is that a dose needs to be set and then injected manually by pushing the actuator button until it stops. In a stressful situation, or if handled by an inexperienced user, the injection may be interrupted mid-way and the button may be released inadvertently. If the button is depressed again, i.e.
- a delivery device for delivering predetermined amounts of medicament comprises a body having an outer housing and an inner housing and having a proximal and an opposite distal end, a cartridge with medicament to be delivered arranged inside said inner housing, said cartridge comprising an opening for expelling said medicament and a stopper movable inside said container, a threaded plunger rod arranged movable inside said body in the longitudinal direction and in contact with said movable stopper, a manually operated push means movable in the longitudinal direction and capable of, upon operation, moving said plunger rod towards said movable stopper, thereby expelling medicament through said opening, and a spring means for biasing said push means towards the distal end of the device, and a first driver and a second driver for transforming a generally linear movement of said push means to a rotational movement of said plunger rod
- the guide frame comprises parallel first and second longitudinally oriented tracks separated by a longitudinally oriented wall element and connected to each other by distal and proximal transversal tracks.
- the guide member is arranged to project into said tracks.
- said manually operated push means in cooperation with said release member, is movably arranged in the longitudinal direction between a depressed position in which the guide member is generally aligned with said distal transversal track and a released position in which the guide member is generally aligned with said proximal transversal track.
- said release member comprises a resilient element and wherein said resilient element is arranged to bias said release member in the transversal direction towards said first position.
- said distal transversal track comprises a longitudinally aligned ramp that is capable of interacting with said guide member to allow movement of said release member from said first position to said second position.
- the first longitudinally oriented track is arranged with a first transversally aligned step ramp at a distal end of said wall element and a second transversally aligned step ramp at a proximal end of said wall element, wherein said first and second step ramps are capable of interacting with said guide member to allow movement of said manually operated push means towards the depressed position and to prevent said manually operated push means from return movement towards the released position.
- said guide member is arranged on a flexible tongue of the release member.
- FIG. 1 is a perspective view of an exemplary medicament delivery device according to the invention.
- FIG. 2 shows, in perspective, a view inside the medicament delivery device of Fig. 1 without the outer housing.
- FIG. 3 illustrates, in perspective, an exploded view of the components of the actuating mechanism of the medicament delivery device of Fig. 1 .
- FIG. 4 illustrates, in perspective, an exploded view of the manually operated push means and the release member of the medicament delivery device of Fig. 1.
- FIGS. 5A - 5F illustrates a sequence of the manually operated push means and the release member in different states of operation.
- FIG. 6A illustrates, in perspective, a second drive member of the medicament delivery device of Fig. 1.
- FIG. 6B illustrates a cross section of FIG 6A.
- FIG. 7 illustrates a cross section of the manually operated push means of the medicament delivery device of Fig. 1.
- FIGS. 8A-8F illustrate, in a sequence of transparent views, the cooperation of a second drive member and a first drive member.
- distal part/end refers to the part/end of the delivery device, or the parts/ends of the members thereof, which is/are located the furthest away from the medicament delivery site of the patient.
- proximal part/end refers to the part/end of the delivery device, or the parts/ends of the members thereof, which, is/are located closest to the medicament delivery site of the patient.
- the guide frame comprises parallel first and second longitudinally oriented tracks separated by a longitudinally oriented wall element and connected to each other by distal and proximal transversal tracks.
- FIG.1 is a perspective view of exemplary components of a complete medicament delivery device 10 according to the invention.
- FIG.1 illustrates the pre-assembled medicament delivery device 10 extending in a longitudinal direction 100.
- Some of the components of the device can be movable in a transversal direction 200 which is orthogonal to the longitudinal direction 100.
- the exemplary delivery device comprises an outer housing 17 arranged with a first view window 1 1 for indicating the remaining amount of medicament.
- a proximal end of the cartridge container 14 projects from the proximal end of the outer housing 17.
- the cartridge container 14 is arranged with a second view window 13 for a user to verify that medicament contents (not shown) have been mixed.
- the cartridge container 14 is also arranged at its proximal end with engaging means 12 as e.g. threads but not restricted to it, such that a delivery member can be connected.
- the delivery member may be a needle, a nozzle, a mouth piece, or the like.
- a release member 20 is movably arranged in the transversal direction 200 and a manually operated push means 30, e.g.
- FIG. 2 is a perspective view that illustrates the medicament delivery device 10 without the outer housing 17 (FIG. 1 ).
- An inner housing 18 is arranged to receive a distal part of the cartridge container 14 by threaded engagement between the outer distal surface of the cartridge container 14 and an inner surface of the inner housing 18.
- a first driver 15 is connected to the distal part of the inner housing 18 to the distal part of the inner housing 18 to the distal part of the inner housing 18 .
- the first driver 15 is arranged with outer threads that engage inner threads of an indicator means 16. Since the indicator means 16 is rotatably locked to the outer housing 17, rotation of the first driver 15 is transformed into longitudinal movement of the indicator means 16 in relation to the outer housing 17 for indicating the remaining amount of medicament through the first view window 11 (FIG. 1 ).
- the release member 20, as shown in FIG. 2, may have an annular form and be arranged in close proximity around the manually operated push means 30.
- a guide member 21 protrudes radially inwards from the release member 20 to engage a guide frame 31 arranged on the outside circumferential surface of the manually operated push means 30.
- the part of the release member 20 that is operated by a patient/user and that protrudes through the outer housing 17, as shown in FIG. 1 may be shaped as a push button.
- the release member is actuated by a user in order to unlock the device for delivery of a dose of medicament. After actuation, the release member 20 is returned by a resilient member 22 that is arranged in a transversally biased position, abutting the inside of the outer housing 17.
- the resilient member 22 depicted in FIG. 2 is in the shape of a flexible finger of the release member, but it could just as well be any other kind of flexible member, e.g. a coil spring.
- the effect might also be attained by a native resilience of the material and/or the shape of the release member 20 itself.
- the cooperation between the guide member 21 and the guide frame 31 ensures the safe and simple delivery of complete doses of medicament, which will be explained in detail below.
- the general function of the exemplary medicament delivery device, as shown in Figures 1 and 2 is described by the following steps. The device is operated by first unlocking and releasing the manually operated push means 30 by depressing the release member 20 in the transversal direction and then actuating the push means 30 in the longitudinal direction.
- a second driver 40 (FIG. 3) is arranged coaxially on the distal part of the first driver 15.
- the distal end of the second driver is arranged coaxially within the manually operated push means 30, acting to transform the longitudinal movement of the push means 30 to rotational movement of the first driver 15, which mechanism will be explained below.
- a plunger rod (not shown) is slidably arranged, but rotatably locked inside the first driver 15 and extends from the inside of the first driver 15 to threaded engagement with a threaded opening at a distal annular surface of the inner housing 18.
- the proximal end of the plunger rod extends into a cartridge (not shown) which is positioned in the cartridge container 14 and is abutting to a movable stopper (not shown) that acts on medicament within the container to drive it towards the delivery member as the plunger rod is actuated by the rotation of the first driver 15. Since the plunger rod is rotatably locked to the first driver 15 and since the inner housing 18 is fixed to the outer housing, the relative rotation of the first driver 15 in relation to the inner housing 18, urges the plunger rod in the longitudinally proximal direction by the threaded engagement between the plunger rod and the inner housing 18.
- the exemplary embodiment is an exploded view of the main components of the invention at the distal end of the medicament delivery device.
- the first driver 15 is rotatable, but movably locked along a longitudinal axis.
- a spring means 18 is arranged in permanent compression between an annular ledge on the distal end of the first driver 15 and on an annular inner surface of the distal end of the second driver 40.
- the second driver is movable, and to a limited extent rotatable, along the longitudinal axis.
- the spring means 18 forces the second driver 40 against the inner surface of the distal end of the manually operated push means 30.
- the manually operated push means 30 is movable along a longitudinal axis.
- the release member 20, which is transversally movable is arranged coaxially with the push means 30 and aligned with the guide frame 31 for the interaction between the release member 20 and the push means 30. The operation of the exemplary embodiment of FIG. 3 will be explained below.
- FIG. 4 shows a perspective view of an exemplary embodiment of the manually operated push means 30 and the release member 20.
- the manually operated push means 30 is arranged with at least one guide frame 31 , such as two guide frames positioned opposite to each other on the circumferential surface of the push means.
- the release member 20 is arranged with at least one guide member 21 , positioned to cooperate with the at least one guide frame 31 .
- the guide frame 31 comprises a first longitudinally oriented track 33 that runs parallel to a second longitudinally oriented track 34. They are separated by a longitudinally oriented wall element 32 and connected to each other by a distal transversal track 35 and a proximal transversal track 36.
- the term track should be interpreted in its widest sense as a path relative to which the guide member 21 may move in a substantially confined manner, i.e. without deviating from the track.
- FIG. 4 shows a guide frame having walls that protrude radially from the surface of the manually operated push means 30 and wherein the proximal transversal track 36 is open towards the proximal side. Since the guide member 21 is arranged on the release member 20, which is movably confined transversally by the outer housing 17, the guide member 21 is still aligned with either of the longitudinal tracks 33, 34 even if it should be positioned proximally to the proximal transversal track 36, i.e.
- the distal transversal track 35 comprises a longitudinally aligned ramp 37.
- the first longitudinally oriented track 33 comprises a first transversally aligned step ramp 38 at a distal end of the wall element 32 and a second transversally aligned step ramp 39 at a proximal end of the wall element 32.
- the guide member 21 may be arranged as a protrusion, e.g. in the form of a step ramp, directed radially inwardly to protrude into the tracks of the guide frame 31 for interaction therewith. Said protrusion being arranged on at least one flexible tongue, or cut-out, on the circumference of the release member 20.
- the manually operated push means 30 is movable in the longitudinal direction while the release member 20 is movable in the transversal direction.
- the manually operated push means 30 is arranged to be movable in the longitudinal direction between a depressed position in which the guide member 21 is generally aligned with said distal transversal track 35 and a released position in which the guide member 21 is generally aligned with said proximal transversal track 36.
- the release member 20 is movably arranged in the transversal direction between a first position in which the guide member 21 is generally aligned with said first track 33 and a second position in which the guide member is generally aligned with said second track 34.
- the manually operated push means 30 is permanently longitudinally biased in the distal, released, direction by the spring means 18 (FIG. 3) and the release member 20 is permanently transversally biased towards the first position by the resilient member 22. Force is required by the user of the device to displace the release member 20 and the push means 30 against their respective biasing directions.
- FIGS. 5A-F illustrated is a sequence of steps that show the operation of the medicament delivery device 10 and the interaction between the manually operated push means 30 and the release member 20.
- the medicament delivery device 10 is in a locked position in which the push means 30 is in the depressed position and is locked from movement towards the released position by an engagement between the guide element 21 and the first transversally aligned step ramp 38.
- the release member is stable in the first position due to the permanent spring bias of the resilient member 22.
- the user has to displace the release member 20 towards the second position by exerting a transversal force on the release member 20 that overcomes the spring bias of the resilient member 22. A certain additional frictional force is required to overcome the resistance presented by the longitudinally aligned ramp 37 in order to lower the risk of accidental unlocking of the device.
- FIG. 5B illustrated is a state where the medicament delivery device 10 has been unlocked wherein the release member 20 is still held in the second position by the user after displacement from the first position (FIG. 5A).
- the manually operated push means is biased towards the released, distal, position by the spring means 18. Consequently the push means 30 is displaced distally towards the released position.
- FIG. 5C shows the push means 30 moving distally towards the released position.
- the push means 30 has reached the released position while the user is still holding the release member 20 in the second position. As he/she lets go of the release member 20, it is returned to the first position by the bias of the resilient member 22, as seen in FIG. 5E.
- the wall element 32 will still hold the guide member 21 and the release member 20 in the second position, thereby preventing return movement of the release member 20 to the first position.
- the guide element 21 aligns with the proximal transversal track 36, allowing return movement of the release member 20.
- FIG. 5F illustrates the push means 30 and the release member 20 after initial depression of the push means 30.
- the second transversally aligned step ramp 39 passes the guide member 21 , making an audible clicking sound as the guide member 21 and the second step ramp 39 snap into locking engagement with each other.
- the only possible movement of the guide member 21 and the push means 30 hereafter is the continued depression of the push means 30.
- the purpose of the second step ramp 39 apart from giving an audible indication to the user, is to prevent the push means 30 from returning to the released position and thereby resetting for a subsequent dose before the current, previously initialized dose has been fully administered.
- the mechanism for resetting the device is explained in conjunction with FIGS. 6-8.
- the push means When completely depressed, the push means is back at the depressed position, shown in FIG. 5A. As the first transversally aligned step ramp 38 passes the guide member 21 , an audible sound is made as the guide member 21 and the first step ramp 38 snap into locking engagement with each other, locking the device and also indicating to the user that the dose has been fully delivered.
- FIGS. 4 and 5A-F a crucial part of the operation of the medicament delivery device 10 is the interaction between the first driver 15 and the second driver 40.
- FIG. 6-8 One such exemplary embodiment is shown in FIG. 6-8.
- FIG. 6A shows a perspective view of the second driver 40, comprising a protruding, longitudinal rib 41 arranged on the outer circumferential surface.
- Inclined ramps 42 are arranged on the distal end surface of the second driver 40.
- FIG. 6B illustrates a cross section of the second driver 40 wherein its inner circumferential surface comprises inside inclined ledges 43 facing generally the proximal direction and return ledges 44 facing generally in the distal direction.
- the inclination of the ledges and number of ledges depend on the amount of medicament to be delivered per dose and are set to predetermined values during manufacturing of the second driver 40.
- FIG. 7 is a cross section of the manually operated push means 30. Longitudinal protruding strips 301 (FIG. 7) are arranged on the inside circumferential surface. A seat 302 is arranged on the inner proximally directed surface of the manually operated push means 30.
- FIGS. 8A-F is a sequence of transparent views of the second driver 40 and the first driver 15 that correspond to the sequence of FIGS. 5A- F.
- FIG. 8A represents the locked position of the medicament delivery device 10, showing the protruding structure 50 of the first driver at the distal end of the inclined ledge 43. Due to the depressed position of the manually operated push means 30 (not shown) the inclined ramps 42 arranged on the distal end of the second driver are pressed into the seat 302 (FIG. 7) by the force of the spring means 18 (not shown), rotationally locking the second driver 40.
- FIGS. 8B-C show that the actuation of the release member 20 towards the second position does not directly affect the drivers (FIG. 8B), but as the push means 30 is displaced towards the released position by the spring means 18, the force of the inclined ramps 42 against the seat 302 is relaxed, allowing the return ledge 44 to slide against the proximal inclined surface 54 of the first driver 15.
- This rotates the second driver 40 in relation to the first driver 15 and the push means 30.
- the rotation is limited by the longitudinal rib 41 of the second driver 40 that is loosely confined between the longitudinally protruding strips 301 (FIG. 7) on the inside circumferential surface of the push means 30.
- Reverse rotation of the first driver 15 during this phase is prevented by the interaction of a structural interface, e.g. a kind of ratchet interface, between the inner distal annular surface of the inner housing 18 and a proximal annular surface of the first driver 15 (not shown).
- the inclined ramps 42 are, again, urged against the seat 302, making the second driver 40 rotate back in relation to the first driver 15 and the push means 30, aligning the distal inclined surface 52 with the proximal end of the inclined ledge 43.
- FIG. 8E represents the state where the release member 20 is returned to the first position (not shown).
- FIG. 8F the user is pressing the push means 30 (not shown) to start expelling a dose of medicament.
- This causes the inclined ledge 43 second driver of the second driver 40 to engage the distal inclined surface 52 of the first driver 15, resulting in rotation of the latter.
- the second driver is rotationally locked due to the engagement between the inclined ramps 42 and the seat 302.
- the plunger rod (not shown) also rotates.
- the motion of the plunger rod urges a stopper (not shown) to expel medicament through the delivery member.
- the push means 30 is dropped by the user at some point during medicament delivery, the engagement between the inclined ledge 43 and the inclined surface 52 is relaxed, but the first driver 15 remains stationary since no force is acting on it. Therefore it is possible to resume and complete the delivery of the dose at any time.
- the push means 30, and consequently the second driver 40 have to be fully depressed, as illustrated in FIG. 8A, before a subsequent dose can be initialized.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2801147A CA2801147C (en) | 2010-06-03 | 2011-05-09 | Medicament delivery device |
EP11790076.1A EP2575937B8 (en) | 2010-06-03 | 2011-05-09 | Medicament delivery device |
US13/701,506 US8926570B2 (en) | 2010-06-03 | 2011-05-09 | Medicament delivery device |
CN201180037203.2A CN103037922B (en) | 2010-06-03 | 2011-05-09 | Medicament delivery device |
JP2013513134A JP5635187B2 (en) | 2010-06-03 | 2011-05-09 | Drug delivery device |
AU2011262408A AU2011262408B2 (en) | 2010-06-03 | 2011-05-09 | Medicament delivery device |
DK11790076.1T DK2575937T3 (en) | 2010-06-03 | 2011-05-09 | Drug delivery device |
BR112012030793-2A BR112012030793A2 (en) | 2010-06-03 | 2011-05-09 | medication delivery device |
KR1020137000080A KR101437795B1 (en) | 2010-06-03 | 2011-05-09 | Medicament delivery device |
RU2012156877/14A RU2534609C2 (en) | 2010-06-03 | 2011-05-09 | Drug delivery device |
ES11790076T ES2716554T3 (en) | 2010-06-03 | 2011-05-09 | Medication administration device |
US14/500,798 US9744309B2 (en) | 2010-06-03 | 2014-09-29 | Medicament delivery device |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35099410P | 2010-06-03 | 2010-06-03 | |
US61/350,994 | 2010-06-03 | ||
SE1050563 | 2010-06-03 | ||
SE1050563-4 | 2010-06-03 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/701,506 A-371-Of-International US8926570B2 (en) | 2010-06-03 | 2011-05-09 | Medicament delivery device |
US14/500,798 Continuation US9744309B2 (en) | 2010-06-03 | 2014-09-29 | Medicament delivery device |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011152772A1 true WO2011152772A1 (en) | 2011-12-08 |
Family
ID=45066969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE2011/050582 WO2011152772A1 (en) | 2010-06-03 | 2011-05-09 | Medicament delivery device |
Country Status (10)
Country | Link |
---|---|
US (2) | US8926570B2 (en) |
EP (1) | EP2575937B8 (en) |
JP (1) | JP5635187B2 (en) |
KR (1) | KR101437795B1 (en) |
CN (1) | CN103037922B (en) |
AU (1) | AU2011262408B2 (en) |
CA (1) | CA2801147C (en) |
RU (1) | RU2534609C2 (en) |
TW (1) | TWI459982B (en) |
WO (1) | WO2011152772A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014139839A1 (en) | 2013-03-12 | 2014-09-18 | Carebay Europe Ltd | Medicament delivery device |
US11607499B2 (en) | 2017-09-15 | 2023-03-21 | Sanofi | Drug delivery device |
US11759575B2 (en) | 2017-11-07 | 2023-09-19 | Sanofi-Aventis Deutschland Gmbh | Injection device |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2475573C (en) | 2002-02-11 | 2013-03-26 | Antares Pharma, Inc. | Intradermal injector |
ES2908027T3 (en) | 2005-01-24 | 2022-04-27 | Antares Pharma Inc | An injector with a pre-filled syringe |
US8251947B2 (en) | 2006-05-03 | 2012-08-28 | Antares Pharma, Inc. | Two-stage reconstituting injector |
WO2007131025A1 (en) | 2006-05-03 | 2007-11-15 | Antares Pharma, Inc. | Injector with adjustable dosing |
US8814834B2 (en) | 2008-03-10 | 2014-08-26 | Antares Pharma, Inc. | Injector safety device |
JP5611208B2 (en) | 2008-08-05 | 2014-10-22 | アンタレス・ファーマ・インコーポレーテッド | Multiple dose injection device |
KR101437795B1 (en) * | 2010-06-03 | 2014-09-03 | 에스에이치엘 그룹 에이비 | Medicament delivery device |
US9220660B2 (en) | 2011-07-15 | 2015-12-29 | Antares Pharma, Inc. | Liquid-transfer adapter beveled spike |
US8496619B2 (en) | 2011-07-15 | 2013-07-30 | Antares Pharma, Inc. | Injection device with cammed ram assembly |
US8834449B2 (en) | 2012-01-23 | 2014-09-16 | Ikomed Technologies, Inc. | Mixing syringe |
US9751056B2 (en) | 2012-01-23 | 2017-09-05 | Merit Medical Systems, Inc. | Mixing syringe |
PT2822618T (en) | 2012-03-06 | 2024-03-04 | Antares Pharma Inc | Prefilled syringe with breakaway force feature |
US9950125B2 (en) | 2012-04-06 | 2018-04-24 | Antares Pharma, Inc. | Needle assisted jet injection administration of testosterone compositions |
WO2013169804A1 (en) | 2012-05-07 | 2013-11-14 | Antares Pharma, Inc. | Needle assisted jet injection device having reduced trigger force |
EP2953667B1 (en) | 2013-02-11 | 2019-10-23 | Antares Pharma, Inc. | Needle assisted jet injection device having reduced trigger force |
EP3572108A1 (en) | 2013-03-11 | 2019-11-27 | Antares Pharma, Inc. | Dosage injector with pinion system |
EP3229872B1 (en) | 2014-12-12 | 2019-01-30 | SHL Medical AG | Dose setting mechanism and medicament delivery device comprising the dose setting mechanism |
EP3344313B1 (en) * | 2015-08-31 | 2021-11-03 | 4C Design Limited | An injector |
USD820438S1 (en) | 2016-06-13 | 2018-06-12 | Carebay Europe Ltd. | Medicament delivery device |
USD820439S1 (en) | 2016-06-13 | 2018-06-12 | Carebay Europe Ltd. | Medicament delivery device |
KR101845655B1 (en) | 2017-02-10 | 2018-05-18 | 최규동 | Safety Cover for Pen type Syringe |
IL308235B1 (en) | 2017-06-30 | 2024-08-01 | Regeneron Pharma | Auto-injector with anti-roll features |
JP1629603S (en) | 2017-10-25 | 2019-04-15 | ||
WO2019185335A1 (en) * | 2018-03-26 | 2019-10-03 | Shl Medical Ag | Medicament container holder |
USD903856S1 (en) | 2018-06-29 | 2020-12-01 | Regeneron Pharmaceuticals, Inc. | Auto-injector |
USD932006S1 (en) | 2018-11-21 | 2021-09-28 | Regeneron Pharmaceuticals, Inc. | Auto-injector cap |
CN110840465B (en) * | 2019-11-30 | 2022-08-26 | 中国人民解放军陆军军医大学第一附属医院 | Automatic retraction blood taking needle |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4252118A (en) * | 1976-04-23 | 1981-02-24 | Jacques Richard | Non-reusable drug prefilled syringe assembly and method of use |
US5496293A (en) * | 1993-04-06 | 1996-03-05 | Medimpex Ets. | Advancing mechanism for an injection device |
US6086567A (en) * | 1996-04-02 | 2000-07-11 | Disetronic Licensing Ag | Injection device |
WO2005097233A2 (en) * | 2004-03-30 | 2005-10-20 | Eli Lilly And Company | Medication dispensing apparatus with spring-driven locking feature enabled by administration of final dose |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5226895A (en) * | 1989-06-05 | 1993-07-13 | Eli Lilly And Company | Multiple dose injection pen |
DE10163326A1 (en) * | 2001-07-30 | 2003-02-27 | Disetronic Licensing Ag | Administration device with dosing device |
DE10229138B4 (en) * | 2002-06-28 | 2008-01-31 | Tecpharma Licensing Ag | Product diverter with piston rod emergency reset |
AU2004283671B2 (en) * | 2003-10-16 | 2010-04-22 | Eli Lilly And Company | Fixed dose medication dispensing device |
ES2369671T3 (en) * | 2004-03-30 | 2011-12-02 | Eli Lilly & Company | MEDICATION DISPENSING DEVICE WITH A GEAR SET THAT HAS AN OPENING HOUSING OF THE DRIVE ELEMENT. |
GB0524604D0 (en) * | 2005-12-02 | 2006-01-11 | Owen Mumford Ltd | Injection method and apparatus |
GB2433032A (en) * | 2005-12-08 | 2007-06-13 | Owen Mumford Ltd | Syringe with dose adjustment means |
DE102006038103B4 (en) * | 2006-08-14 | 2017-02-23 | Tecpharma Licensing Ag | Injection device with variable thread guide |
PL2234661T3 (en) * | 2007-12-20 | 2013-09-30 | Novo Nordisk As | Injection device for delivering a fixed dose of liquid drug |
RS52103B (en) * | 2008-05-02 | 2012-06-30 | Sanofi-Aventis Deutschland Gmbh | Medication delivery device |
JP5611208B2 (en) * | 2008-08-05 | 2014-10-22 | アンタレス・ファーマ・インコーポレーテッド | Multiple dose injection device |
EP2208503A1 (en) * | 2009-01-20 | 2010-07-21 | Sanofi-Aventis Deutschland GmbH | Drive assembly and medication delivery device |
GB0918145D0 (en) * | 2009-10-16 | 2009-12-02 | Owen Mumford Ltd | Injector apparatus |
KR101437795B1 (en) * | 2010-06-03 | 2014-09-03 | 에스에이치엘 그룹 에이비 | Medicament delivery device |
-
2011
- 2011-05-09 KR KR1020137000080A patent/KR101437795B1/en active IP Right Grant
- 2011-05-09 CN CN201180037203.2A patent/CN103037922B/en active Active
- 2011-05-09 JP JP2013513134A patent/JP5635187B2/en active Active
- 2011-05-09 US US13/701,506 patent/US8926570B2/en active Active
- 2011-05-09 WO PCT/SE2011/050582 patent/WO2011152772A1/en active Application Filing
- 2011-05-09 RU RU2012156877/14A patent/RU2534609C2/en active
- 2011-05-09 AU AU2011262408A patent/AU2011262408B2/en not_active Ceased
- 2011-05-09 CA CA2801147A patent/CA2801147C/en active Active
- 2011-05-09 EP EP11790076.1A patent/EP2575937B8/en active Active
- 2011-06-02 TW TW100119329A patent/TWI459982B/en active
-
2014
- 2014-09-29 US US14/500,798 patent/US9744309B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4252118A (en) * | 1976-04-23 | 1981-02-24 | Jacques Richard | Non-reusable drug prefilled syringe assembly and method of use |
US5496293A (en) * | 1993-04-06 | 1996-03-05 | Medimpex Ets. | Advancing mechanism for an injection device |
US6086567A (en) * | 1996-04-02 | 2000-07-11 | Disetronic Licensing Ag | Injection device |
WO2005097233A2 (en) * | 2004-03-30 | 2005-10-20 | Eli Lilly And Company | Medication dispensing apparatus with spring-driven locking feature enabled by administration of final dose |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014139839A1 (en) | 2013-03-12 | 2014-09-18 | Carebay Europe Ltd | Medicament delivery device |
US10881807B2 (en) | 2013-03-12 | 2021-01-05 | Shl Medical Ag | Medicament delivery device |
US11872380B2 (en) | 2013-03-12 | 2024-01-16 | Shl Medical Ag | Medicament delivery device |
US11607499B2 (en) | 2017-09-15 | 2023-03-21 | Sanofi | Drug delivery device |
US11759575B2 (en) | 2017-11-07 | 2023-09-19 | Sanofi-Aventis Deutschland Gmbh | Injection device |
Also Published As
Publication number | Publication date |
---|---|
JP2013527004A (en) | 2013-06-27 |
CN103037922A (en) | 2013-04-10 |
EP2575937B1 (en) | 2019-02-06 |
US20130218098A1 (en) | 2013-08-22 |
RU2012156877A (en) | 2014-07-20 |
EP2575937A4 (en) | 2017-11-29 |
EP2575937A1 (en) | 2013-04-10 |
TW201201875A (en) | 2012-01-16 |
CN103037922B (en) | 2015-08-26 |
CA2801147A1 (en) | 2011-12-08 |
CA2801147C (en) | 2015-02-24 |
TWI459982B (en) | 2014-11-11 |
US20150045742A1 (en) | 2015-02-12 |
US8926570B2 (en) | 2015-01-06 |
JP5635187B2 (en) | 2014-12-03 |
KR20130045319A (en) | 2013-05-03 |
AU2011262408A1 (en) | 2012-12-20 |
EP2575937B8 (en) | 2019-04-03 |
RU2534609C2 (en) | 2014-11-27 |
AU2011262408B2 (en) | 2013-03-21 |
KR101437795B1 (en) | 2014-09-03 |
US9744309B2 (en) | 2017-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9744309B2 (en) | Medicament delivery device | |
DK2414005T3 (en) | Drug delivery device | |
US20110034878A1 (en) | Device for injecting apportioned doses of liquid drug | |
KR101976299B1 (en) | Dose setting mechanism and medicament delivery device comprising the dose setting mechanism | |
TW201244768A (en) | Medicament delivery device | |
US20240100261A1 (en) | Medicament delivery device | |
CN107427643B (en) | Drug delivery device | |
EP2301611B1 (en) | Medical delivery device | |
US8926566B2 (en) | Medicament delivery device | |
CN113164684A (en) | Locking member for injection device and injection device trainer | |
DK2575937T3 (en) | Drug delivery device | |
CN113168783A (en) | Latch for injection device and injection device trainer | |
CN113164693B (en) | Reset connector for injection device and injection device trainer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201180037203.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11790076 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011790076 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2801147 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2013513134 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3753/KOLNP/2012 Country of ref document: IN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2011262408 Country of ref document: AU Date of ref document: 20110509 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20137000080 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2012156877 Country of ref document: RU Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13701506 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012030793 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012030793 Country of ref document: BR Kind code of ref document: A2 Effective date: 20121203 |